Clinical Trials Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Jan 7, 2024; 30(1): 79-90
Published online Jan 7, 2024. doi: 10.3748/wjg.v30.i1.79
Table 1 Demographic and clinical characteristics of the training group and validation groups (mean ± SD)
CharacteristicTraining group
Validation group
LGC (n = 998)
LTG (n = 572)
LDG (n = 426)
LGC (n = 398)
LTG (n = 165)
LDG (n = 233)
Age59.8 (11.31)60.0 (11.22)59.6 (11.44)57.8 (12.4)59.2 (12.2)57.0 (12.4)
Gender
Female3071561511734582
male691416275342120151
BMI22.6 (3.2)22.9 (3.2)22.3 (3.2)22.6 (3.4)22.7 (3.6)22.5 (3.4)
ASA score
2964556408365148217
3341618331716
ECOG score
08104603501426973
1158986023189142
230141625718
Severe heart disease41322175
Severe lung disease105518126
Hypertension1407169783939
Diabetes673037522725
Operative time (min)240 (63.0)246.8 (73.1)230.9 (44.6)280.9 (76.4)308.0 (86.1)267.2 (68.9)
Bleeding volume (min)130.5 (115.4)147.8 (128.5)107.3 (90.0)54.3 (57.6)78.7 (67.4)57.9 (51.6)
Blood transfusion (mL)25.5 (138.1)34.3 (172.3)13.62 (67.9)19.0 (132.4)11.0 (65.1)22.0 (154.0)
Complication1396475785127
ClavienDindo
0859508351320114206
1145917107
2933459563818
329245532
4312000